Trailing-twelve-month (TTM) revenue is $2.49 Billion with a year-over-year growth of (2.08%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $626,439,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $642,269,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $613,845,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $606,927,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $2,489,480,000 |
Current P/S: $1,139,158,680 market capitalization ÷ $2,489,480,000 TTM revenue = 0.46x.
Market capitalization source: FMP quote. Quote observed 2026-09-21T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $606.93M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-22T11:11:16.028Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Other | N/A | N/A | $354M | $438M |
| Other.. | $303M | $320M | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Foreign. | N/A | $13M | N/A | N/A | N/A | N/A |
| Non Us | $818,000 | N/A |
$2.49B
$2.49 Billion
(2.08%)
vs. $2.54B a year ago (TTM)
+8.85%
5 Year compound annual growth rate
1 Year
(2.08%)
3 Year
(0.55%)
5 Year
+8.85%
10 Year
+38.49%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.53B | ($39.60M) | (1.54%) |
| 2024 | $2.57B | ($32.84M) | (1.26%) |
| 2023 | $2.60B | +$195.57M | +8.13% |
| 2022 | $2.41B | +$374.13M | +18.41% |
| 2021 | $2.03B | +$938.75M | +85.81% |
| 2020 |
TTM Growth
(2.08%)
3-Year CAGR
(0.55%)
5-Year CAGR
+8.85%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-22T11:11:16.028Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| N/A |
| N/A |
| N/A |
| Non-US | N/A | N/A | N/A | $365M | $410M | $458M |
|---|
| Other | N/A | N/A | $306M | N/A | N/A | N/A |
|---|
| U | $206M | N/A | N/A | N/A | N/A | N/A |
|---|
| United States | N/A | $242M | $2.1B | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | $2.2B | $2.2B | $2.1B |
|---|
| $1.09B |
| +$540.65M |
| +97.71% |
| 2019 | $553.31M | +$135.40M | +32.40% |
| 2018 | $417.91M | +$184.63M | +79.14% |
| 2017 | $233.28M | +$110.12M | +89.42% |
| 2016 | $123.16M | +$45.77M | +59.15% |
